OAYLX | VIVIX | OAYLX / VIVIX | |
Total Expense Ratio | 0.87 | 0.04 | 2,175% |
Annual Report Gross Expense Ratio | 0.87 | 0.04 | 2,175% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | 4.640 | 6.215 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.3B | 189B | 4% |
Annual Yield % from dividends | 0.42 | 2.19 | 19% |
Returns for 1 year | 19.70 | 12.05 | 163% |
Returns for 3 years | 65.32 | 35.17 | 186% |
Returns for 5 years | 133.23 | 80.14 | 166% |
Returns for 10 years | N/A | 115.68 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CICEX | 63.05 | 0.60 | +0.96% |
American Funds Invmt Co of Amer 529E | |||
JABZX | 10.61 | 0.10 | +0.95% |
JHancock Global Environmental Opps A | |||
GMYPX | 17.53 | 0.14 | +0.81% |
Goldman Sachs Large Cap Value P | |||
ETADX | 19.59 | 0.10 | +0.51% |
Eventide Dividend Growth A | |||
JFNCX | 55.38 | 0.03 | +0.05% |
Janus Henderson Global Life Sciences C |